Research & Development in
Tägerwilen

STL Systems AG

Since 2009 · 1–10 empl.

The core activity of STL Systems AG is the development and manufacture of innovative sensor and system concepts for measuring and analyzing magnetic fields and other signature parameters. The company offers a wide range of products and services, including mobile survey systems, stationary measurement systems, magnetometers, metal detectors and coil systems, as well as customized services such as development, calibration and underwater surveying.

Eugenex Biotechnologies GmbH

Since 1999 · 1–10 empl.

Eugenex Biotechnologies GmbH develops expression cell lines and process solutions for animal component‑free production of biosimilars and novel biopharmaceuticals. The GeneXpress technology platform includes CHOSI host cell lines, protein‑free MAM‑PF media and pMOZ expression plasmids, and the company offers ready‑to‑go biosimilar processes, cell line and process development, gram‑scale protein production (non‑GMP), analytical and cell‑based assays and technology transfer.

Stiftung Regena Akademie

Since 2002 · 11–20 empl.·5.0(2)

Stiftung Regena Akademie offers training courses and seminars on REGENA therapy. The institution provides continuing education for physicians, naturopaths, therapists in natural healing methods, and pharmacists, with a focus on applying REGENA therapy.

InGeneron AG

Since 2025 · 1–10 empl.

InGeneron AG is a biotechnology company that develops cell-based therapies and regenerative cell therapies. Its focus is on research and development for orthopedic applications as well as a technology platform for isolating and using regenerative cells.

enzymmanagement ag

Since 2007 · 1–10 empl.

enzymmanagement ag develops and produces bioactive cosmeceutical and topical treatments targeting benign fatty‑tissue tumors and certain rare diseases such as multiple symmetric lipomatosis and estradiol‑dependent breast cancer. Its developments are based on intracrinological and biochemical principles of local steroid production and metabolism in target tissues.

mo lens gmbh

Since 2013 · 1–10 empl.

The core activity of Molens GmbH is the development and manufacture of special contact lenses.

AgroSuisse AG

Since 2021 · 1–10 empl.